Patient Preferences for Chronic Myeloid Leukemia Medication Regimen Attributes and their Potential Impact on Adherence: Results from a Multi-national Conjoint Study

Background: Tyrosine kinase inhibitors (TKIs) have significantly improved survival for patients with chronic myeloid leukemia (CML) but require long-term administration and non-adherence due to regimen requirements has been reported. Objectives: This study sought to identify how much patients value...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirji, Ishan, Grinspan, Jessica, Flood, Emuella, Chirovsky, Diana, Devlen, Jennifer, Wagner, Samuel, Davis, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471412/
https://www.ncbi.nlm.nih.gov/pubmed/37664084
http://dx.doi.org/10.36469/9890

Ejemplares similares

Ejemplares similares